CVS Health Corp. buy Morgan Stanley
Summary
This prediction ended on 04.08.24 with a price of €53.88. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.74%. Morgan_Stanley has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €2.42 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 0.873% | 0.873% | 83.288% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Morgan_Stanley for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.